We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

1 hedge funds and large institutions have $66K invested in Medicines Co in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 278 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 284 → 1 (-283)

100% less funds holding in top 10

Funds holding in top 10: 38 → 0 (-38)

100% less capital invested

Capital invested by funds: $8.36B → $66K (-$8.36B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 278

Holders
1
Holders Change
-283
Holders Change %
-99.65%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-38
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
278
Calls
$12.9M
Puts
–
Net Calls
+$12.9M
Net Calls Change
-$160M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.03B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$648M
3
SCM
Sarissa Capital Management
Connecticut
-$357M
4
HI
HBK Investments
Texas
-$330M
5
FCM
Farallon Capital Management
California
-$282M
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
26
Boxer Capital
California
– -$82.1M -967,000 Closed
UOC
27
UBS O'Connor
Illinois
– -$82.1M -966,509 Closed
WIC
28
Water Island Capital
New York
– -$81.7M -962,241 Closed
Macquarie Group
29
Macquarie Group
Australia
– -$77.3M -911,519 Closed
Northern Trust
30
Northern Trust
Illinois
– -$76.2M -897,455 Closed
Bank of New York Mellon
31
Bank of New York Mellon
New York
– -$73.7M -867,706 Closed
SPC
32
Slate Path Capital
New York
– -$69.5M -818,042 Closed
IA
33
IndexIQ Advisors
New York
– -$67.9M -799,904 Closed
LPC
34
Lion Point Capital
New York
– -$66.6M -783,950 Closed
PCM
35
Pentwater Capital Management
Florida
– -$66.3M -780,500 Closed
VI
36
Versor Investments
New York
– -$63.3M -744,836 Closed
BCM
37
Beryl Capital Management
California
– -$60.4M -711,667 Closed
CC
38
Carlson Capital
Texas
– -$60.1M -707,322 Closed
GF
39
Gabelli Funds
New York
– -$58.5M -688,792 Closed
PSAMP
40
P. Schoenfeld Asset Management (PSAM)
New York
– -$56.8M -669,062 Closed
MWNA
41
Marshall Wace North America
New York
– -$56.2M -661,541 Closed
Principal Financial Group
42
Principal Financial Group
Iowa
– -$51.5M -606,414 Closed
Renaissance Technologies
43
Renaissance Technologies
New York
– -$51.4M -605,132 Closed
DFO
44
Duquesne Family Office
New York
– -$49.7M -585,500 Closed
Ameriprise
45
Ameriprise
Minnesota
– -$48.3M -568,953 Closed
Norges Bank
46
Norges Bank
Norway
– -$48.2M -566,881 Closed
JP Morgan Chase
47
JP Morgan Chase
New York
– -$46.5M -547,883 Closed
MCP
48
Moab Capital Partners
New York
– -$44.3M -521,987 Closed
GLAM
49
Gardner Lewis Asset Management
Pennsylvania
– -$44M -517,519 Closed
SCS
50
Syquant Capital SAS
France
– -$42.9M -505,030 Closed
1
2
3 4 5

MDCO Hedge Fund Activity: Q1 2020 in Review

1 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q1 2020, worth a combined $66K — down 100% from $8.36B a quarter earlier.

Sellers outnumbered buyers: 278 funds closed out of MDCO and 0 opened new positions — a net loss of 278 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $1.03B sold.

  • 1 institutional investor held Medicines Co (MDCO) as of Q1 2020, down from 284 in Q4 2019.
  • Funds reported $66K of Medicines Co stock for Q1 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Medicines Co positions in Q1 2020 and 278 closed out, a net change of -278 holders.
  • The largest Medicines Co seller in Q1 2020 was BlackRock, an estimated $1.03B sold.

Based on aggregated 13F filings for Q1 2020.